|
|
||||||||
From the Division of Neurology, Neuromuscular Diseases Section, Barrow Neurological Institute, Phoenix, AZ.
Address correspondence and reprint requests to Dr. K. Sivakumar, Barrow Neurological Institute, 240 W. Thomas Rd., Phoenix, AZ 85013; e-mail: ksivakumar{at}chw.edu
The molecular basis for the clinically distinct entity of deafness with Charcot-Marie-Tooth disease has not been established with certainty. The authors report deafness associated with a demyelinating neuropathy in three individuals of a family in whom a novel fouramino acid deletion in the PMP22 gene was identified. The data and review of literature suggest that in the PMP22 gene, some point mutations and small deletions in the transmembrane domain that are in close proximity to the extracellular component of the protein result in this clinically distinct entity.
This article has been cited by other articles:
![]() |
H. -J. Kim, S. H. Hong, C. -S. Ki, B. -J. Kim, J. -S. Shim, S. -H. Cho, J. -H. Park, and J. -W. Kim A novel locus for X-linked recessive CMT with deafness and optic neuropathy maps to Xq21.32-q24 Neurology, June 14, 2005; 64(11): 1964 - 1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Aho, R. C. Wallace, A. M. Pitt, and K. Sivakumar Charcot-Marie-Tooth Disease: Extensive Cranial Nerve Involvement on CT and MR Imaging AJNR Am. J. Neuroradiol., March 1, 2004; 25(3): 494 - 497. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |